Rapid vigilance and episodic memory decrements in COVID-19 survivors.
Rapid vigilance and episodic memory decrements in COVID-19 survivors.
复制标题
DOI:
10.1093/braincomms/fcab295
复制
发表时间:
2022
影响因子:
4.8
通讯作者:
Husain M
中科院分区:
文献类型:
--
作者:
Zhao S;Shibata K;Hellyer PJ;Trender W;Manohar S;Hampshire A;Husain M
Recent studies indicate that COVID-19 infection can lead to serious neurological consequences in a small percentage of individuals. However, in the months following acute illness, many more suffer from fatigue, low motivation, disturbed mood, poor sleep and cognitive symptoms, colloquially referred to as ‘brain fog’. But what about individuals who had asymptomatic to moderate COVID-19 and reported no concerns after recovering from COVID-19? Here, we examined a wide range of cognitive functions critical for daily life (including sustained attention, memory, motor control, planning, semantic reasoning, mental rotation and spatial–visual attention) in people who had previously suffered from COVID-19 but were not significantly different from a control group on self-reported fatigue, forgetfulness, sleep abnormality, motivation, depression, anxiety and personality profile. Reassuringly, COVID-19 survivors performed well in most abilities tested, including working memory, executive function, planning and mental rotation. However, they displayed significantly worse episodic memory (up to 6 months post-infection) and greater decline in vigilance with time on task (for up to 9 months). Overall, the results show that specific chronic cognitive changes following COVID-19 are evident on objective testing even amongst those who do not report a greater symptom burden. Importantly, in the sample tested here, these were not significantly different from normal after 6–9 months, demonstrating evidence of recovery over time. Zhao et al. reported COVID-19 survivors who had asymptomatic to moderate COVID-19 showed a faster decline in vigilance and worse episodic memory compared with the age-matched controls. Reassuringly, the differences disappear after 6–9 months demonstrating evidence of recovery over time.
登录
查看更多内容
DOI:
10.2967/jnumed.121.262128
发表时间:
2021-07-01
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
Blazhenets G;Schroeter N;Bormann T;Thurow J;Wagner D;Frings L;Weiller C;Meyer PT;Dressing A;Hosp JA
通讯作者:
Hosp JA
影响因子:
3.3
作者:
Ferrucci R;Dini M;Groppo E;Rosci C;Reitano MR;Bai F;Poletti B;Brugnera A;Silani V;D'Arminio Monforte A;Priori A
通讯作者:
Priori A
影响因子:
15.1
作者:
Hampshire A;Trender W;Chamberlain SR;Jolly AE;Grant JE;Patrick F;Mazibuko N;Williams SC;Barnby JM;Hellyer P;Mehta MA
通讯作者:
Mehta MA
影响因子:
14.5
作者:
Hosp, Jonas A.;Dressing, Andrea;Meyer, Philipp T.
通讯作者:
Meyer, Philipp T.
影响因子:
3.4
作者:
Duckworth, Angela Lee;Quinn, Patrick D.
通讯作者:
Quinn, Patrick D.